Navigation Links
New Report on 633 Biotechnology Medicines Under Development Released in Michigan
Date:9/24/2008

DETROIT, Sept. 24 /PRNewswire-USNewswire/ -- As the nation combats an alarming rise in chronic diseases, the Pharmaceutical Research and Manufacturers of America (PhRMA) today released a new report on the next generation of medicines in research pipelines that offer hope to millions of patients.

The report found that America's pharmaceutical research and biotechnology companies - including several located in Michigan - are testing a record 633 new biotech medicines.

Today's report was released in Michigan due to the growing prominence of the state's biotech sector in developing and testing cutting-edge medicines. Michigan's life sciences industry has become one of the nation's fastest-growing regions, with 112 new biotechnology companies formed in the state since 2000 - including a number of companies that research and develop new medicines.

"The biotechnology revolution is helping create medicines that use unprecedented technologies, such as nano-sized particles that seek out and kill viruses, ways to actually regenerate healthy muscle to replace damaged heart tissue, and gene therapy," said PhRMA Senior Vice President Ken Johnson. "The impact of this research is felt worldwide. Such critical innovation is creating medicines with the potential to help millions of patients live longer, healthier and more productive lives."

"We are proud of the increasingly important role of Michigan's pharmaceutical biotechnology sector in developing and testing cutting-edge medicines," said Stephen Rapundalo, Ph.D., president of MichBio, the association for Michigan's biosciences industry. "MichBio is committed to providing new hope for patients and to driving the continued growth of Michigan's life sciences industry that makes this possible."

All of the experimental medicines in the report are being tested in human clinical trials or await approval by the U.S. Food and Drug Administration.

The 633 biotechnology medicines being d
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Neogen Reports 26% Increase in Revenues
2. Sangui Bio Tech International Inc. Shareholders Meeting Delayed to Include FY 2008 Report
3. MIGENIX Reports First Quarter Fiscal 2009 Financial Results
4. Friends of the Earth Report on Biofuel Production Offers Incomplete, Outdated and Inaccurate Picture, According to Brazilian Sugarcane Industry Association
5. Long-Term Investments Remain Critical to Biotechnology Industry Growth, According to a New Report by Global Industry Analysts
6. Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
7. Injectable CTM Manufacturing Market Report Now Available
8. ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent
9. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009
10. Sangui BioTech International, Inc. Files Remaining Reports
11. Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014 Research and Markets ... and Proteomics Analytical Instruments Market 2014-2018" report to ... Genomics is the study of the gene ... the structure and functions of proteomes or sets of ... technology. Genomics involves the mapping of genes and DNA ...
(Date:7/24/2014)... July 24, 2014  CorMedix Inc. (NYSE MKT: ... commercializing therapeutic products for the prevention and treatment ... of notice on July 18, 2014 from the ... accepted the CorMedix plan to regain compliance with ... result, the NYSE-MKT is continuing the Company,s listing ...
(Date:7/24/2014)... 24, 2014  Neogen Corporation (Nasdaq: NEOG ... its potential revenue from new rodenticide research are premature. ... analysts on July 22, 2014, Neogen,s CEO commented about ... research. "It was my intent Tuesday at ... of a new type of rodenticide, but certainly not ...
(Date:7/24/2014)... 24, 2014 The first part of ... in First in Human Studies” will cover comprehensive clinical ... decisions. , With increasing R&D costs and declining industry ... to maximize the knowledge collected in early Phase I/IIa ... success in late stage development. , Next, the presenters ...
Breaking Biology Technology:Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Neogen comments on SenesTech 2Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
... ends the second quarter with more than $535 million in cash ... EDT at ... http://www.isispharm.com , CARLSBAD, Calif., Aug. 7 Isis,Pharmaceuticals, Inc. ... ended June 30, 2008. The Company ended the quarter,in the strongest financial ...
... /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a,company focused ... of diseases and personalized health management, today reported,operational ... year to date,ended June 30, 2008., "The ... blood,test to assess a patient,s current risk of ...
... CHAMPAIGN, Ill. By combining stretchable optoelectronics and ... imaging device, with a layout based on the ... issue of the journal Nature, researchers ... have developed a high-performance, hemispherical "eye" camera using ...
Cached Biology Technology:Isis Reports Financial Results and Highlights for Second Quarter of 2008 2Isis Reports Financial Results and Highlights for Second Quarter of 2008 3Isis Reports Financial Results and Highlights for Second Quarter of 2008 4Isis Reports Financial Results and Highlights for Second Quarter of 2008 5Isis Reports Financial Results and Highlights for Second Quarter of 2008 6Isis Reports Financial Results and Highlights for Second Quarter of 2008 7Isis Reports Financial Results and Highlights for Second Quarter of 2008 8Isis Reports Financial Results and Highlights for Second Quarter of 2008 9Isis Reports Financial Results and Highlights for Second Quarter of 2008 10Isis Reports Financial Results and Highlights for Second Quarter of 2008 11Isis Reports Financial Results and Highlights for Second Quarter of 2008 12Isis Reports Financial Results and Highlights for Second Quarter of 2008 13Isis Reports Financial Results and Highlights for Second Quarter of 2008 14GeneNews Announces Second Quarter Results 2GeneNews Announces Second Quarter Results 3GeneNews Announces Second Quarter Results 4GeneNews Announces Second Quarter Results 5GeneNews Announces Second Quarter Results 6GeneNews Announces Second Quarter Results 7GeneNews Announces Second Quarter Results 8Stretchable silicon camera next step to artificial retina 2
(Date:7/25/2014)... that the age girls reach puberty is influenced by ,imprinted ... parent contributes the gene. This is the first evidence ... birth and details of this study were published today in ... period, known as menarche, is a marker for the timing ... onset of menses varies between girls, is an inherited trait, ...
(Date:7/25/2014)... use of a molecular testing panel developed at ... correct initial surgery for patients with thyroid nodules ... Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter., ... Center and other diagnostic testing agencies, improved the ... by 30 percent, according to the study published ...
(Date:7/25/2014)... Florida , July 25, 2014 ... more consumers are turning to digital technology for online ... (OTCBB: NXTD), Google Inc. (NASDAQ: GOOG ), ... (NYSE: V ), Apple Inc. (NASDAQ: ... NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company ...
Breaking Biology News(10 mins):Could age of first period influence development of diseases in older women? 2Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 4Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 5Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 6
... of scientists has, for the first time, completely characterized an ... ground-level ozone in urban areas. The team,s results indicate that ... during episodes of poor air quality (smoggy days) by as ... poses significant health hazards to people, animals and plants; is ...
... JOLLA, Calif., November 1, 2010 One of the many ... fat, which in turn supports a healthy heart. Fat tissue ... it,s also an active secretory organ that normally produces ... protects the hearts of healthy people has long been a ...
... " Environmental Pollution " details successful experiments at ... in the abiotic (non-biological) transformation and absorption of ... of these estrogen hormones by more than 80 ... implications since it could point to inexpensive treatment ...
Cached Biology News:Study improves accuracy of models for predicting ozone levels in urban areas 2Study improves accuracy of models for predicting ozone levels in urban areas 3Study improves accuracy of models for predicting ozone levels in urban areas 4Study finds fat hormone's long-sought link to heart protection 2UC research: Rabbit's food brings luck in decreasing estrogen levels in wastewater 2UC research: Rabbit's food brings luck in decreasing estrogen levels in wastewater 3
These disposable button tethers are designed for rat infusion studies lasting more than 2 weeks. After one to two weeks the subcutaneous tissue will grow into the Dacron mesh, making the sutures irre...
Mycoplasma and virus tested...
... Western Protein Standards are specifically designed ... weight estimation directly on western blots. ... binding site, allowing direct visualization with ... detect your target protein on the ...
... Clone/PAD: 3F10B10. Immunogen: ... internal region of JAB1 (Jun ... Specificity: Specific for the ... (positive controls: 293T Jurkat cell ...
Biology Products: